IndraLab
Statements
Hydroxychloroquine activates IL6. 6 / 6
|
6
reach
"In a randomised, double-blinded, placebo-controlled clinical trial of 40 asymptomatic patients with HIV-1, 800 mg/d hydroxychloroquine treatment for 8 weeks reduced the plasma concentration of HIV-1 RNA, preserved CD4+ T-cell counts and proliferative responses, and lowered serum IL-6 concentrations, compared with the placebo group.63 Although it takes 1–3 months for hydroxychloroquine and chloroquine to fully take effect in patients with rheumatic disease, the drugs' anti-viral effect is relatively rapid."
reach
"These pharmacological agents comprise non-specific immune modulators, such as corticosteroids, hydroxychloroquine, interferons, cardiovascular drugs, such as statins and renin–angiotensin–aldosterone system (RAAS) inhibitors, and specific immune modulators, such as Janus kinase (Jak) inhibitors, humanized anti-interleukin-6 (IL-6), anti-IL-1 receptor and anti-tumor necrosis factor alpha (TNF-α) monoclonal antibodies (34–41)."